The Kirklin Clinic
Birmingham, Alabama, 35249, United States
Location status: Recruiting
NCT Number: NCT06294574
The purpose of the study is to test how successful the retrieval rate of the new HydroMARK Plus Breast Biopsy Site Marker in comparison to HydroMARK.
Interested in participating?
Request Info18 year–90 year
Female
Interventional
Not applicable
Birmingham, Alabama, 35249, United States
Location status: Recruiting
Study objectives
Primary objective
Assess the successful retrieval rates of the HydroMARK Plus clip
Secondary objective
Determine the level of satisfaction of the surgeon with the retrieval of the HydroMARK Plus clip
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each patient will undergo a breast localization procedure, and a HydroMARK plus clip will be placed.
Time frame: Date of HydroMARK Plus Clip placement to 1 week plus or minus 5 days
The primary endpoint of HydroMARK Plus retrieval rate will be estimated with % and two-sided 95% CI using normal approximation. A paired McNemar Test will be used to compare HydroMARK Plus retrieval rate and HydroMARK retrieval rate, and the 95% CI for the difference of retrieve rate will be estimated using the Newcombe's Score method.
Time frame: Date of retrieval surgery to 1 week.
Surgeon satisfaction will be evaluated using a Likert scale survey.
Contact information is provided by the study sponsor or research team.
University of Alabama at Birmingham
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07273812
Accuracy of AI App, Behavior
Baghdad, Iraq
View Trial DetailsNCT05582499
Breast Cancer, Breast Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT06072612
Breast Cancer, Breast Cancer Metastatic
Phoenix, Arizona, United States
View Trial DetailsNCT06268665
Adnexal Diseases, Breast Cancer
Sacramento, California, United States
View Trial Details